Do you want to read an article? Please log in or register.
TALON Phase IIIb Study: 32 Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age Related Macular Degeneration
Macular Diseases
Related content
Macular Diseases
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmol Ther
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group
doi: 10.1007/s40123-024-00983-2
Macular Diseases
MERLIN: Two-Year Results of Brolucizumab in Participants With Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Ophthalmology
Brown DM, Jaffe GJ, Wykoff CC, Adiguzel E, Heier JS, Khanani AM
doi: 10.1016/j.ophtha.2024.08.022
Macular Diseases
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration
J Clin Med
Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group
doi: 10.3390/jcm14072370
Macular Diseases
Efficacy and safety of brolucizumab every 6 weeks induction therapy for neovascular age-related macular degeneration
Sci Rep
Honda S, Maruyama-Inoue M, Otsuji T, Kyo A, Kobayashi Y, Yamamoto Y, Gomi F
doi: 10.1038/s41598-025-89638-1
Macular Diseases
Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series
BMC Ophthalmol
Bantounou MA, Elsheikh M, Ijasan A, Santiago C
doi: 10.1186/s12886-025-03953-9
Macular Diseases
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
Ophthalmol Ther
Cancian G, Paris A, Agliati L, Rizzato A, Clerici M, Volpe G, Menghini M, Grimaldi G
doi: 10.1007/s40123-024-01036-4
Macular Diseases
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
Int J Retina Vitreous
Grimaldi G, Cancian G, Paris A, Clerici M, Volpe G, Menghini M
doi: 10.1186/s40942-024-00586-w
Macular Diseases
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial
Ophthalmol Retina
Hamouz J, Nowosielska A, Święch-Zubilewicz A, Abengoechea S, Baumane K, Vajas A, Siewierska M, Veselovsky M, Veith M, Kerényi Á, Mange S, Baidya K, Laganovska G, Jürgens I, Papp A, Gosai J, Štefanickova J, Han M, Fryczkowski P, Zalewski D, Wang J, Wei W
doi: 10.1016/j.oret.2024.10.001
COMMENTED
Macular DiseasesRetinal Diseases
Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Lee MY, Han K, Min KH, Yu DS, Lee YB
doi: 10.1016/j.ajo.2024.08.033